1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Neuromodulation Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Neuromodulation Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Neuromodulation Market Regional Analysis
6.2 Middle East and Africa Neuromodulation Market Revenue 2017-2027 (US$ Million)
6.3 Middle East and Africa Neuromodulation Market Forecast Analysis
7. Middle East and Africa Neuromodulation Market Analysis – by Technology
7.1 External Neuromodulation
- 7.1.1 Overview
- 7.1.2 External Neuromodulation: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Internal Neuromodulation
- 7.2.1 Overview
- 7.2.2 Internal Neuromodulation: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Middle East and Africa Neuromodulation Market Analysis – by Application
8.1 Chronic Pain Management
- 8.1.1 Overview
- 8.1.2 Chronic Pain Management: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Failed Back Syndrome
- 8.2.1 Overview
- 8.2.2 Failed Back Syndrome: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Epilepsy
- 8.3.1 Overview
- 8.3.2 Epilepsy: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Tremor
- 8.4.1 Overview
- 8.4.2 Tremor: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Incontinence
- 8.5.1 Overview
- 8.5.2 Incontinence: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Depression
- 8.6.1 Overview
- 8.6.2 Depression: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.7 Dystonia
- 8.7.1 Overview
- 8.7.2 Dystonia: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.8 Gastroparesis
- 8.8.1 Overview
- 8.8.2 Gastroparesis: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.9 Parkinson's Disease
- 8.9.1 Overview
- 8.9.2 Parkinson's Disease: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.10 Obsessive-Compulsive Disorder
- 8.10.1 Overview
- 8.10.2 Obsessive-Compulsive Disorder: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.11 Migraine
- 8.11.1 Overview
- 8.11.2 Migraine: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Middle East and Africa Neuromodulation Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Home Healthcare
- 9.3.1 Overview
- 9.3.2 Home Healthcare: Middle East and Africa Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Middle East and Africa Neuromodulation Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa
- 10.2.1 Middle East and Africa Neuromodulation Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Middle East and Africa Neuromodulation Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 South Africa:
Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by Technology
- 10.2.1.1.2 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by Application
- 10.2.1.1.3 South Africa: Middle East and Africa Neuromodulation Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia:
Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by Technology
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by Application
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Neuromodulation Market Breakdown, by End User
- 10.2.1.3 UAE:
Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 UAE: Middle East and Africa Neuromodulation Market Breakdown, by Technology
- 10.2.1.3.2 UAE: Middle East and Africa Neuromodulation Market Breakdown, by Application
- 10.2.1.3.3 UAE: Middle East and Africa Neuromodulation Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by Technology
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by Application
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Neuromodulation Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Medtronic
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 NeuroPace, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 NeuroSigma, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NEVRO CORP.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Soterix Medical Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Integer Holdings Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Magstim
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Middle East and Africa Neuromodulation Market
